Enzymotec Patents – Insights & Stats (Updated 2024)

Enzymotec has a total of 343 patents globally, out of which 175 have been granted. Of these 343 patents, more than 26% patents are active. The United States of America is where Enzymotec has filed the maximum number of patents, followed by Israel and China. Parallelly, Israel seems to be the main focused R&D centre and also is the origin country of Enzymotec.

Enzymotec was founded in 1999. Enzymotec produces and sells lipid-based bioactive ingredients used in various medical and nutritional products. Their ingredients help in reducing cholesterol, treating attention disorders, and slowing cognitive decline in adults. These products support the nutritional supplement, healthcare, medical foods, and infant formula industries, enabling them to create advanced infant foods and nutritional supplements.

Do read about some of the most popular patents of Enzymotec which have been covered by us in this article and also you can find Enzymotec patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Enzymotec patent portfolio.

How many patents does Enzymotec have?

Enzymotec has a total of 343 patents globally. These patents belong to 54 unique patent families. Out of 343 patents, 92 patents are active.

How Many Patents did Enzymotec File Every Year?

Enzymotec Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEnzymotec Applications FiledEnzymotec Patents Granted
20231
20223
2021114
20204
201918
2018114
20171413
20162313
20153014
20141616
2013522

How many Enzymotec patents are Alive/Dead?

Worldwide Patents

Enzymotec Patent Portfolio

How Many Patents did Enzymotec File in Different Countries?

Enzymotec Worldwide Patent Filing

Countries in which Enzymotec Filed Patents

CountryPatent
United States of America43
Israel31
China25
Korea (South)24
Europe (EPO)23
Hong Kong (S.A.R.)17
India16
Japan15
Germany14
Austria13
Brazil12
Canada12
Spain9
Australia9
Russian Federation8
New Zealand8
Mexico6
Denmark6
Singapore4
Viet Nam3
Malaysia2
Indonesia2
Argentina1
Taiwan1
Philippines1
South Africa1
Slovenia1

Where are Research Centers of Enzymotec Patents Located?

R&D Centres of Enzymotec

10 Best Enzymotec Patents

WO2005036987A1 is the most popular patent in the Enzymotec portfolio. It has received 88 citations so far from companies like Pfizer, Bunge Loders Croklaan, Friesland Brands.

Below is the list of 10 most cited patents of Enzymotec:

Publication NumberCitation Count
WO2005036987A188
WO2006114791A184
US20050130937A149
US20090232916A144
WO2009057121A141
WO2005037373A137
WO2009016632A133
US7935365B225
WO2011135564A125
US20050054621A124

What are Enzymotec key innovation segments?

What Technologies are Covered by Enzymotec?

The chart below distributes patents filed by Enzymotec in different countries on the basis of the technology protected in patents. It also represents the markets where Enzymotec thinks it’s important to protect particular technology inventions.

R&D Focus: How has Enzymotec search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Enzymotec?

Related Articles

Terasi Ab Patents – Insights & Stats (Updated 2024)

Terasi Ab has a total of 7 patents globally, out of which 2 have been granted. Of these 7 patents, more than 85% patents are active. Sweden is where Terasi Ab has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, Sweden seems

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.